Cita APA (7a ed.)
Liang, J., Chen, M., Yan, G., Hoa, P. T. T., Wei, S., Huang, H., . . . Han, C. (Dec 2025). Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01550-6
Cita Chicago Style (17a ed.)
Liang, Jiaming, et al. "Donafenib Activates the P53 Signaling Pathway in Hepatocellular Carcinoma, Induces Ferroptosis, and Enhances Cell Apoptosis." Clinical and Experimental Medicine Dec 2025. https://doi.org/10.1007/s10238-024-01550-6.
Cita MLA (9a ed.)
Liang, Jiaming, et al. "Donafenib Activates the P53 Signaling Pathway in Hepatocellular Carcinoma, Induces Ferroptosis, and Enhances Cell Apoptosis." Clinical and Experimental Medicine, Dec 2025, https://doi.org/10.1007/s10238-024-01550-6.
Precaución: Estas citas no son 100% exactas.